Discovery of antimycin-type depsipeptides from a wbl gene mutant strain of deepsea-derived Streptomyces somaliensis SCSIO ZH66 and their effects on pro-inflammatory cytokine production

Frontiers in Microbiology

Volumn 8, Issue APR, 2017, Pages

  Li, Huayue ^a   Huang, Huiming ^a   Hou, Lukuan ^a   Ju, Jianhua ^b   Li, Wenli ^a,c  

^a Ocean University of China   (China)

^b SOUTH CHINA SEA INSTITUTE OF OCEANOLOGY   (China)

^c QINGDAO NATIONAL LABORATORY FOR MARINE SCIENCE AND TECHNOLOGY   (China)

Author keywords

Anti inflammatory; Antimycin type depsipeptides; Deepsea derived bacteria; IL 5 production; Regulatory gene

Indexed keywords

CITRININ; DEPSIPEPTIDE; DEXAMETHASONE; INTERLEUKIN 5; SOMALIMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEEP SEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNIZATION; INHIBITION ZONE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MOUSE; MTT ASSAY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPECTROSCOPY; SPLEEN CELL; STREPTOMYCES; STREPTOMYCES SOMALIENSIS; STRUCTURE ACTIVITY RELATION; UMBILICAL VEIN ENDOTHELIAL CELL; WBL GENE;

EID: 85018955087     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00678     Document Type: Article

References (21)

1. Bachmann, B. O., Van Lanen, S. G., and Baltz, R. H. (2014). Microbial genome mining for accelerated natural products discovery: Is a renaissance in the making? J. Ind. Microbiol. Biotechnol. 41, 175-184. doi: 10.1007/s10295-013-1389-9
2. Baltz, R. H. (2016). Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes. J. Ind. Microbiol. Biotechnol. 43, 343-370. doi: 10.1007/s10295-015-1682-x
3. Challis, G. L. (2008). Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology 154, 1555-1569. doi: 10.1099/mic.0.2008/018523-0
4. Hosotani, N., Kumagai, K., Nakagawa, H., Shimatani, T., and Saji, I. (2005). Antimycins A10 approximately A16, seven new antimycin antibiotics produced by Streptomyces spp. SPA-10191 and SPA-8893. J. Antibiot. 58, 460-467. doi: 10.1038/ja.2005.61
5. Huang, H., Hou, L., Li, H., Qiu, Y., Ju, J., and Li, W. (2016). Activation of a plasmid-situated type III PKS gene cluster by deletion of a wbl gene in deepsea-derived Streptomyces somaliensis SCSIO ZH66. Microb. Cell Fact. 15:116. doi: 10.1186/s12934-016-0515-6
6. Kollar, P., Rajchard, J., Balounova, Z., and Pazourek, J. (2014). Marine natural products: bryostatins in preclinical and clinical studies. Pharm. Biol. 52, 237-242. doi: 10.3109/13880209.2013.804100
7. Komoda, T., Morimitsu, Y., Hirota, H., and Hirota, A. (1995). USF-19A, a new lipoxygenase inhibitor from Streptomyces sp. Biosci. Biotechnol. Biochem. 59, 924-926. doi: 10.1271/bbb.59.924
8. Lane, A. L., and Moore, B. S. (2011). A sea of biosynthesis: marine natural products meet the molecular age. Nat. Prod. Rep. 28, 411-428. doi: 10.1039/C0NP90032J
9. Liu, G., Kuang, S., Wu, S., Jin, W., and Sun, C. (2016). A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo. Sci. Rep. 6:26722. doi: 10.1038/srep26722
10. Liu, J., Zhu, X., Kim, S. J., and Zhang, W. (2016). Antimycin-type depsipeptides: discovery, biosynthesis, chemical synthesis, and bioactivities. Nat. Prod. Rep. 33, 1146-1165. doi: 10.1039/c6np00004e
11. Liu, J., Zhu, X., Seipke, R. F., and Zhang, W. (2015). Biosynthesis of antimycins with a reconstituted 3-formamidosalicylate pharmacophore in Escherichia coli. ACS Synth. Biol. 4, 559-565. doi: 10.1021/sb5003136
12. Newman, D. J., and Cragg, G. M. (2004). Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 67, 1216-1238. doi: 10.1021/np040031y
13. Rangel, M., and Falkenberg, M. (2015). An overview of the marine natural products in clinical trials and on the market. J. Coast. Life Med. 3, 421-428. doi: 10.12980/JCLM.3.2015JCLM-2015-0018
14. Raveh, A., Delekta, P. C., Dobry, C. J., Peng, W., Schultz, P. J., Blakely, P. K., et al. (2013). Discovery of potent broad spectrum antivirals derived from marine actinobacteria. PLoS ONE 8:e82318. doi: 10.1371/journal.pone.0082318
15. Salomon, C. E., Magarvey, N. A., and Sherman, D. H. (2004). Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. Nat. Prod. Rep. 21, 105-121. doi: 10.1039/B301384G
16. Shiomi, K., Hatae, K., Hatano, H., Matsumoto, A., Takahashi, Y., Jiang, C. L., et al. (2005). A new antibiotic, antimycin Ag, produced by Streptomyces sp. K01-0031. J. Antibiot. 58, 74-78. doi: 10.1038/ja.2005.10
17. Skropeta, D. (2008). Deep-sea natural products. Nat. Prod. Rep. 25, 1131-1166. doi: 10.1039/b808743a
18. Skropeta, D., and Wei, L. (2014). Recent advances in deep-sea natural products. Nat. Prod. Rep. 31, 999-1025. doi: 10.1039/c3np70118b
19. Strangman, W. K., Kwon, H. C., Broide, D., Jensen, P. R., and Fenical, W. (2009). Potent inhibitors of pro-inflammatory cytokine production produced by a marine-derived bacterium. J. Med. Chem. 52, 2317-2327. doi: 10.1021/jm801110j
20. Yao, C. B. F., Schiebel, M., Helmke, E., Anke, H., and Laatsch, H. (2006). Prefluostatin and new urauchimycin derivatives produced by Streptomycete isolates. Z. Naturforsch. 61, 320-325.
21. Zhang, Y., Huang, H., Xu, S., Wang, B., Ju, J., Tan, H., et al. (2015). Activation and enhancement of fredericamycin A production in deepsea-derived Streptomyces somaliensis SCSIO ZH66 by using ribosome engineering and response surface methodology. Microb. Cell Fact. 14:64. doi: 10.1186/s12934-015-0244-2